Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Aug 9;42(9):422.
doi: 10.1007/s12032-025-02973-1.

From cell cycle control to cancer therapy: exploring the role of CDK1 and CDK2 in tumorigenesis

Affiliations
Review

From cell cycle control to cancer therapy: exploring the role of CDK1 and CDK2 in tumorigenesis

Jitendra Gupta et al. Med Oncol. .

Abstract

The cyclin-dependent kinase (CDK) family comprises one of the most common types of serine/threonine kinases responsible for controlling many cellular processes through the action of the dynamics of these enzymes. The CDKs are regulators of cellular processes, ranging from cell cycle progression, an integral step of cellular lifespan involved in its division and growth, to the expression of genes and the transfer of genetic information from DNA to RNA. CDK-related pathology is primarily based on the dysregulation of CDK, resulting in improper coordination of the cell cycle and leading to uncontrolled proliferation. The CDK1 involved in the G2 to M-phase transition interacts with CENPF, PVT1, and TFCP2L1, which affects chromosome segregation and cell proliferation. Besides the previously described partners, namely PRDX2 and C/EBPα, the CDK2 responsible for the G1/S transition has also been shown to bind TBK1 and modulate DNA synthesis and cell cycle checkpoints. Such mechanisms of action contribute to oncogenesis through interactions, including roles for lncRNAs and miRNAs in modulating the expression and activity of CDKs. Their importance in cancer has made CDK1/2 critical candidates for anticancer drug targeting. The dysregulation of CDK1/2 manifests in cancer pathology, which is, in turn, associated with an uncoordinated normal cell cycle and resultant proliferation. This study aims to provide a comprehensive overview of the diverse functions of CDK1 and CDK2 in cancer, thereby facilitating the exploration of their therapeutic potential and the development of novel cancer therapy designs. The complexity of targeting CDK1 and CDK2 highlights the importance of their regulation during cancer development. It indicates their substantial promise as valid targets for therapy, in vitro and vivo studies, and human sample analysis.

Keywords: CDK1; CDK2; Cancer; Cell Cycle Regulation; Cyclin-Dependent Kinases; Oncogenesis; Proliferation.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: There is no conflict of interest.

Similar articles

References

    1. Angelin A. Cyclin-dependent kinases regulate the adult nervous system via the one-carbon-metabolism. Cell Death Dis. 2023;14(7):429. - PubMed - PMC
    1. Thin KZ, Liu X, Feng X, Raveendran S, Tu JC. LncRNA-DANCR: a valuable cancer related long non-coding RNA for human cancers. Pathol Res Pract. 2018;214(6):801–5. - PubMed
    1. Colas P. Cyclin-dependent kinases and rare developmental disorders. Orphanet J Rare Dis. 2020;15(1): 203. - PubMed - PMC
    1. Grison A, Atanasoski S. Cyclins, cyclin-dependent kinases, and cyclin-dependent kinase inhibitors in the mouse nervous system. Mol Neurobiol. 2020;57(7):3206–18. - PubMed
    1. Gutierrez-Chamorro L, Felip E, Ezeonwumelu IJ, Margelí M, Ballana E. Cyclin-dependent kinases as emerging targets for developing novel antiviral therapeutics. Trends Microbiol. 2021;29(9):836–48. - PubMed

LinkOut - more resources